Is APHE or MRK a better dividend investment in 2026?

APHE currently yields 40.00% with a 5% 5-year dividend growth rate. MRK yields 3.25% with 8.2% growth. The better choice depends on your goal: APHE offers higher current income.

What is the dividend yield difference between APHE and MRK?

APHE has a forward dividend yield of 40.00% ($2.00/share annually). MRK yields 3.25% ($3.08/share annually). The yield gap is 36.75 percentage points.

Home › Compare › APHE vs MRK

APHE vs MRK: Dividend Comparison 2026

APHE yields 40.00% · MRK yields 3.25%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 APHE wins by $201.1K in total portfolio value

INVESTMENT

TIME HORIZON10 years

APHE

● Live price

40.00%

Share price

$5.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$231.9K

Annual income

$39,181.04

Full APHE calculator →

MRK

Merck & Co. Inc.

● Live price

3.25%

Share price

$94.80

Annual div

$3.08

5Y div CAGR

8.2%

Payout ratio

42%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$950.29

Full MRK calculator →

Portfolio growth — APHE vs MRK

📍 APHE pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	APHE	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, APHE + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

APHE pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

APHE

Annual income on $10K today (after 15% tax)

$3,400.00/yr

After 10yr DRIP, annual income (after tax)

$33,303.88/yr

MRK

Annual income on $10K today (after 15% tax)

$276.16/yr

After 10yr DRIP, annual income (after tax)

$807.75/yr

At 15% tax rate, APHE beats the other by $32,496.14/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of APHE + MRK for your $10,000?

APHE: 50%MRK: 50%

100% MRK50/50100% APHE

Portfolio after 10yr

$131.3K

Annual income

$20,065.67/yr

Blended yield

15.28%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

APHE

No analyst data

Altman Z

3.5

Piotroski

1/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+35.6% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

APHE buys

MRK buys

No recent congressional trades found for APHE or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricAPHEMRK

Forward yield	40.00% ✓	3.25%
Annual dividend / share	$2.00	$3.08 ✓
Payout ratio	50%	42% ✓
1-year div growth	0%	5.5% ✓
5-year div CAGR	0%	8.2% ✓
Portfolio after 10y	$231.9K ✓	$30.7K
Annual income after 10y	$39,181.04 ✓	$950.29
Total dividends collected	$174.4K ✓	$6.1K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: APHE vs MRK ($10,000, DRIP)

Year	APHE Portfolio	APHE Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$14,700	$4,000.00	$11,192	$351.54	+$3.5K → APHE
2	$21,224	$5,495.33	$12,524	$392.70	+$8.7K → APHE
3	$30,125	$7,415.26	$14,015	$438.65	+$16.1K → APHE
4	$42,071	$9,836.48	$15,682	$489.96	+$26.4K → APHE
5	$57,854	$12,838.17	$17,547	$547.23	+$40.3K → APHE
6	$78,403	$16,499.54	$19,632	$611.16	+$58.8K → APHE
7	$104,788	$20,897.28	$21,963	$682.53	+$82.8K → APHE
8	$138,226	$26,102.79	$24,571	$762.18	+$113.7K → APHE
9	$180,082	$32,179.61	$27,486	$851.08	+$152.6K → APHE
10	$231,869	$39,181.04	$30,745	$950.29	+$201.1K → APHE

APHE vs MRK: Complete Analysis 2026

APHE — Stock

Alpha Energy, Inc., an independent oil and gas company, engages in the acquisition, exploration, development, production, and sale of natural gas and crude oil in the United States. It holds interest in the Coral Project, which covers an area of 1,100 acres located in Lincoln and Logan Counties in Central Oklahoma. The company was incorporated in 2013 and is based in Golden, Colorado. Houston, Texas. Alpha Energy, Inc. operates as a subsidiary of AEI Acquisition LLC.

Full APHE Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →

📬

Get this APHE vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

APHE vs SCHD APHE vs JEPI APHE vs O APHE vs KO APHE vs MAIN APHE vs JNJ APHE vs ABBV APHE vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.